Endocrine (2018) 62:271–273 https://doi.org/10.1007/s12020-018-1632-2 EDITORIAL Primary hyperparathyroidism in prostate cancer: guilty or not guilty? 1 2 3 ● ● G. Mazziotti S. Frara A. Mosca Received: 9 March 2018 / Accepted: 9 May 2018 / Published online: 30 May 2018 © Springer Science+Business Media, LLC, part of Springer Nature 2018 Skeletal health is a clinically relevant issue in patients with probability to express PHPT. Notably, PC with the best prostate cancer (PC) [1–3]. Bone is the most common site of prognostic characteristics was considered “protective for PC cell migration with up to 90% of patients with advanced PHPT” by Minisola et al. . disease having bone metastases  with potential negative The pathophysiological determinants of these associa- impact on quality of life and survival . Since the ﬁrst tions were not clariﬁed in this study, but the authors description of the “seed and soil” hypothesis by Stephan hypothesized that in patients with higher PC activity/bio- Paget in 1889 , several cellular signaling pathways, logical aggressiveness, as assessed by high GS, osteo- cytokines, chemokines, and adhesion molecules have been blastic bone metastases may favor the development of identiﬁed as players of cross-talking between PC cells and PHPT by decreasing serum
Endocrine – Springer Journals
Published: May 30, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud